Fragrance-Free vs Unscented: Read the Ingredients Behind the Claim

For someone trying to avoid fragrance in skincare, fragrance-free is the more useful starting claim. Unscented can mean that fragrance was added to cover other ingredients’ odor without leaving an obvious scent. Neither claim guarantees that a product will suit your skin. Compare the ingredient list with any allergens you already know you need to avoid; a smell test cannot do that job. U.S. Food and Drug Administration; American Academy of Dermatology.

The distinction matters when two bottles seem to promise the same thing. An unscented cream listing fragrance has not necessarily contradicted its claim about smell. A fragrance-free product listing a botanical extract still needs closer reading. The question is which substances are present and relevant to you, rather than which front label sounds more reassuring.

What the claims tell you—and what they leave unanswered

AAD’s nummular-eczema guidance describes fragrance-free as excluding ingredients added to give a product a particular smell, and recommends it over unscented. That is useful clinical shopping guidance for that condition; it is not an FDA certification or a promise of tolerance for every reader. American Academy of Dermatology.

FDA explicitly says that hypoallergenic has no federal standard or definition and does not require manufacturers to submit substantiation of that claim to the agency. That statement concerns hypoallergenic. It does not establish that a fragrance-free product was independently tested or that its manufacturer excluded masking scents. U.S. Food and Drug Administration.

The AAD page also uses the word hypoallergenic in its eczema advice. Read the two sources together: a professional society can recommend a product description while FDA explains that the same description has no standardized federal meaning. For purchasing, the useful follow-up is to examine the actual formula and your clinician’s avoidance advice, rather than add up reassuring words.

EPA’s October 2016 fact sheet describes fragrance-free certification as an addition to a qualifying Safer Choice label. It addresses both scenting materials and masking scents. This is a specific verification program, not a cosmetics-wide legal definition. A plain fragrance-free statement on a moisturizer does not show that EPA evaluated it, and a certification about fragrance cannot identify every possible personal allergy. U.S. Environmental Protection Agency.

Why an unscented product can contain fragrance

FDA explains that some manufacturers add enough fragrance to cover the unpleasant smell of other ingredients while leaving no noticeable scent. This establishes the possibility of masking; it does not establish how often the practice occurs across products or whether an individual cream will cause a reaction. The absence of a smell is therefore weak evidence about the absence of fragrance. U.S. Food and Drug Administration.

A practical example is an unscented cleanser whose ingredient panel includes fragrance. If your goal is specifically to avoid fragrance, that panel answers the immediate shopping question better than the front claim. It does not tell you which individual materials make up the blend. If you have a diagnosed allergy, ask about your named trigger rather than asking only whether the product smells perfumed.

Fragrance itself is not evidence that a cosmetic is unsafe for everyone. FDA says fragrance ingredients must meet the same safety requirements as other cosmetic ingredients, and that manufacturers are responsible for safe, properly labeled products. Individual allergy and ordinary product safety are different questions. This guide concerns avoiding relevant exposures, not ranking every scented and unscented product by danger. U.S. Food and Drug Administration.

Why a US ingredient list may name a blend instead of its components

21 CFR 701.3 generally requires cosmetic ingredient declarations in descending order of predominance, with exceptions. Paragraph (a) permits fragrance and flavor to be declared collectively. It also provides for FDA-accepted trade-secret ingredients to be represented by the phrase and other ingredients. Fragrance is therefore not the only disclosure exception, and flavor shares the collective-declaration provision. Office of the Federal Register / U.S. Government Publishing Office.

For a reader, the distinction is between a declared ingredient category and a complete list of its constituents. Seeing fragrance tells you that the category is present, but usually does not resolve whether a particular fragrance allergen is inside it. Not seeing an individually named allergen also cannot, by itself, establish that the substance is absent from a blend.

The current label panel can help you reject an obvious mismatch with an avoidance plan. It cannot function as a laboratory report. Treat a missing detail as an unanswered question, especially when you already know the specific substance you react to. Manufacturer confirmation may help clarify a formula, but a general reply repeating fragrance-free does not answer a question about a named constituent.

What laboratory testing found in fragrance-free products

Lu and colleagues’ 2021 Taiwan-market study used gas chromatography–mass spectrometry to measure 27 target fragrance allergens. Among 31 products claiming fragrance-free, five contained measured target substances. The abstract describes 82 products overall; a later sentence says 81 while listing groups totaling 82. That inconsistency is a reporting limitation. This was a small market surveillance study, not a representative survey of US skincare. Journal of Food and Drug Analysis.

Section 3.5 reports limonene, linalool, geraniol and citronellol in the fragrance-free group. Its reported linalool range in the lotion, toothpaste and cleanser examples is 5–78 micrograms per gram. Another product declared benzyl alcohol as a preservative. The implicated products listed plant extracts or essential oils. Detection therefore does not, on its own, show concealed perfume, illegal labeling, or an allergic reaction in users. Journal of Food and Drug Analysis.

The useful inference is narrower than a failure rate for an entire product category: a front claim did not exclude every measured fragrance allergen in these samples. The study did not test your bottle, all fragrance materials, or your personal tolerance. It also cannot establish that every plant extract contains an important amount of an allergen. Keep the measurement, the label claim and the clinical outcome separate.

The European Commission’s linked SCCS document is a pre-consultation scientific opinion adopted in December 2011. It notes that a fragrance substance used for another purpose, such as preservation, can expose an allergic person even in a fragrance-free product. That explains why a substance’s function matters. The opinion is scientific advice, not a US labeling rule or a certification of any particular formula. Scientific Committee on Consumer Safety.

For example, the right question about benzyl alcohol is not simply whether its name sounds like perfume. Ask what is present and whether it is relevant to your diagnosed allergy. A preservative function does not make a relevant allergen disappear; equally, finding the name does not diagnose allergy in someone who has never reacted to it.

Fragrance-free does not cover every contact allergen

The NACDG 2023–2024 report, published online October 1, 2026, describes 3,979 patch-tested patients; 70.3% had at least one positive allergic patch-test reaction. Selected results below show fragrance markers alongside a preservative. These percentages concern people undergoing clinical testing, not the probability that a shopper will react to a product. Dermatitis.

This is a selected comparison, not the study’s full ranking. The tested population was 74.3% female and 69.9% White. Referral patterns and test selection limit generalization, including to other demographic groups. A positive test also needs assessment for relevance to the person’s rash and exposures. The table cannot rank commercial products or establish that a particular preservative will trouble everyone. Dermatitis.

For product selection, removing fragrance addresses one question. It leaves others open. If a dermatologist has identified a preservative allergy, a fragrance-free claim does not answer whether that preservative is present. Conversely, a reader without that allergy should not turn a clinic test percentage into a universal instruction to avoid all preservatives or substitute an allegedly safer system.

US and EU disclosure: read the rule’s scope and dates

As checked October 28, 2026, the RegInfo entry for RIN 0910-AI90 lists fragrance-allergen disclosure at the proposed-rule stage and schedules an NPRM for November 2026. It also records the statutory NPRM deadline of June 29, 2024. An agenda target is a plan, not a published proposal, final rule, effective date, or assurance that labels will change next month. Office of Information and Regulatory Affairs / U.S. General Services Administration.

FDA’s MoCRA overview confirms that the law requires fragrance-allergen labeling regulations. It also describes companies’ responsibility to maintain adequate safety substantiation. Neither requirement turns a fragrance-free claim into FDA product approval. Read older FDA fragrance information alongside this later rulemaking framework; do not use a pre-MoCRA explanation of FDA authority to dismiss the law’s new requirements. U.S. Food and Drug Administration.

For the wider implementation context, see our guide to pending MoCRA cosmetic rules. Here, the shopping implication is simply that a scheduled US rule should not be treated as information already printed on the bottle.

For EU-market cosmetics, Regulation (EU) 2023/1545 expands individual fragrance-allergen disclosure. Its provisions use concentrations exceeding 0.001% in leave-on products and 0.01% in rinse-off products. These are labeling thresholds, not personal allergy safety thresholds. Its transition provisions allowed relevant noncompliant products to be placed on the market until July 31, 2026, with further supply permitted until July 31, 2028. European Union.

Those are two different events: first entry onto the market and later supply of stock already there. The transition means labels on sale during this period need not all look alike. This comparison explains disclosure under the cited 2023 regulation; it is not an exhaustive guide to every EU ingredient restriction. A US bottle and an EU bottle with different lists also should not be assumed to contain identical formulas.

More individually named allergens can mean more disclosure, rather than a worse product. But a longer list alone does not prove that the only difference is labeling. Compare the actual products and market versions before drawing either conclusion. The absence of a named substance is especially hard to interpret where collective declarations, concentration thresholds or transition stock are involved.

Use the ingredient panel to resolve the purchase decision

The following table is a reading aid, not a diagnostic screen or a list of ingredients everyone must avoid. Its purpose is to identify the next useful question. Compare exact names with an existing clinician-provided avoidance list, rather than trying to decide from a chemical-sounding name whether an ingredient is good or bad.

Consider two hypothetical bottles: A says unscented and lists fragrance; B says fragrance-free and lists lavender oil and limonene. Bottle A gives clear evidence of fragrance on its panel. Bottle B raises a different question about named substances and the botanical ingredient. Neither front claim is enough to choose a product for someone with a diagnosed allergy. If limonene is on that person’s avoidance list, its explicit appearance matters more than the fragrance-free wording.

If you contact a manufacturer, make the question specific: does this exact formula contain the substance named on my avoidance list, including within its fragrance or botanical ingredients? Keep the answer tied to the product version you are considering. If the answer is unavailable, the uncertainty remains; it should not be converted into a claim that the product is either safe or deceptive.

If a product has caused a reaction

Stop using a suspected product and seek assessment for persistent or recurring symptoms. Do not deliberately reapply a product that has already caused a significant reaction to settle the label question. A dermatologist can assess whether patch testing is appropriate. DermNet describes diagnosis as combining history with testing, with results interpreted against the rash distribution and products used. DermNet NZ.

Fragrance allergy can develop hours to days after exposure, and fragrance can be transferred from the hands to another site. Timing and location alone therefore cannot reliably identify the culprit. Record products used, when symptoms appeared and where they occurred; bring ingredient panels and any existing allergy results to the appointment. This is preparation for an assessment, rather than a way to diagnose yourself. DermNet NZ.

Keep the purchase question manageable: first establish what the label claims, then what the ingredient panel actually discloses, then whether the disclosed or uncertain substances matter for your skin. Fragrance-free can help narrow a search. A personal avoidance plan and appropriate clinical evaluation answer questions that the front of the bottle cannot.

Sources

• U.S. Food and Drug Administration. Fragrances in Cosmetics

• U.S. Food and Drug Administration. Hypoallergenic Cosmetics

• Office of the Federal Register / U.S. Government Publishing Office. 21 CFR 701.3 - Designation of ingredients

• Office of Information and Regulatory Affairs / U.S. General Services Administration. Unified Agenda RIN 0910-AI90 - Disclosure of Fragrance Allergens in Cosmetic Labeling (proposed rule stage)

• U.S. Food and Drug Administration. Modernization of Cosmetics Regulation Act of 2022 (MoCRA)

• European Union. Commission Regulation (EU) 2023/1545 amending Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in cosmetic products

• Scientific Committee on Consumer Safety. Fragrance allergens in cosmetic products: SCCS/1459/11, pre-consultation opinion, December 2011

• Journal of Food and Drug Analysis. Quantitative analysis of fragrance allergens in various matrixes of cosmetics by liquid-liquid extraction and GC-MS (Lu CH et al., J Food Drug Anal 2021;29(4):700-708)

• Dermatitis. North American Contact Dermatitis Group Patch Test Results: 2023-2024 (PMID 42817757)

• American Academy of Dermatology. Eczema types: Nummular eczema self-care

• U.S. Environmental Protection Agency. Safer Choice Fact Sheet - Fragrance-Free (EPA 950-F-16-004)

• DermNet NZ. Fragrance allergy (DermNet)